Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    January 2023
  1. CHEN D, Cao J, Tian L, Liu F, et al
    [Retracted] Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species‑mediated mitochondrial signaling pathways.
    Oncol Rep. 2023;49:11.
    PubMed     Abstract available


    November 2022
  2. RAMLI I, Susworo S, Nuranna L, Mansyur M, et al
    Circadian as a prognostic factor for radiation responses in patients with cervical cancer: A nested casecontrol study.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  3. ZHOU L, Li H, Zhang D, Chen L, et al
    OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    October 2022
  4. LIU C, Feng H, Song L, Li S, et al
    Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  5. XING F, Song Z, Cheng Z
    High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    September 2022
  6. WANG Z, He S, Guo P, Guo X, et al
    [Retracted] MicroRNA1297 inhibits metastasis and epithelialmesenchymal transition by targeting AEG1 in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  7. LIAO H, Pan Y, Pan Y, Shen J, et al
    [Retracted] MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    May 2022
  8. XIAO W, Zhou S, Xu H, Li H, et al
    [Corrigendum] NogoB promotes the epithelialmesenchymal transition in HeLa cervical cancer cells via Fibulin5.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    April 2022
  9. ZHANG W, Wang C, Hu X, Lian Y, et al
    Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    December 2021
  10. ZHAO Q, Zhai YX, Liu HQ, Shi YA, et al
    [Retracted] MicroRNA4915p suppresses cervical cancer cell growth by targeting hTERT.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    November 2021
  11. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  12. LIU L, Shi W, Xiao X, Wu X, et al
    BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP1 cells via the Rb/E2F1 pathway in cervical carcinoma.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    July 2021
  13. SONG X, Shi B, Huang K, Zhang W, et al
    [Retracted] miR133a inhibits cervical cancer growth by targeting EGFR.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  14. CHU J, Gao J, Wang J, Li L, et al
    Mechanism of hydrogen on cervical cancer suppression revealed by highthroughput RNA sequencing.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    June 2021
  15. DEZEN T, Rossini RR, Spadin MD, Da Cunha Andrade CEM, et al
    Accuracy of MRI for diagnosing pelvic and paraaortic lymph node metastasis in cervical cancer.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    May 2021
  16. WANG J, Xiang F, Liu X, Ma X, et al
    HPV E7 affects the function of cervical cancer cells via the TAL1/lncEBIC/KLHDC7B axis.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  17. YANG X, Du H, Bian W, Li Q, et al
    FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  18. OUYANG F, Liu J, Xia M, Lin C, et al
    [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    April 2021
  19. YOU X, Wang Y, Meng J, Han S, et al
    Exosomal miR663b exposed to TGFbeta1 promotes cervical cancer metastasis and epithelialmesenchymal transition by targeting MGAT3.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available


  20. CHEN J, Chen H, Pan L
    SIRT1 and gynecological malignancies (Review).
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    February 2021
  21. SHEN Z, Song W, Qian L, Zhu J, et al
    Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma.
    Oncol Rep. 2021;45:606-618.
    PubMed     Abstract available


    November 2020
  22. LIU H, Li Y, Zhang J, Wu N, et al
    ErbB2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53responsive microRNA31845p in cervical cancer cells.
    Oncol Rep. 2020 Nov 19. doi: 10.3892/or.2020.7862.
    PubMed     Abstract available


    October 2020
  23. WANG A, Liu L, Yuan M, Han S, et al
    Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
    Oncol Rep. 2020 Oct 21. doi: 10.3892/or.2020.7819.
    PubMed     Abstract available


    July 2020
  24. SI J, Zhang J, Gan L, Guo M, et al
    The effects of the Wnt/betacatenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.
    Oncol Rep. 2020;44:303-312.
    PubMed     Abstract available


    May 2020
  25. MA HR, Cao L, Wang F, Cheng C, et al
    Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Oncol Rep. 2020;43:1536-1546.
    PubMed     Abstract available


    April 2020
  26. ICHIKAWA R, Kawasaki R, Iwata A, Otani S, et al
    MicroRNA1263p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
    Oncol Rep. 2020;43:1300-1308.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: